Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- What is IMedis's primary focus?
- IMedis is developing an AI-driven cloud-based quality management system for radiology departments, aggregating and analyzing data from PACS and RIS to reduce risk, improve financial efficacy, and create new business opportunities.
- What is Duali-Q and what is its purpose?
- Duali-Q is IMedis's first commercially available module, designed for the management and follow-up of errors of omission in CT scans of the chest and abdomen. It has been shown to increase detection rates of life-threatening diseases by 13% in a recent study.
- Where is Duali-Q currently in use?
- Duali-Q is currently in use by teaching hospitals in the United States, United Kingdom, and Israel.
- When was IMedis founded?
- IMedis was founded in January 2018.
- What was IMedis's first funding round?
- In April 2018, IMedis raised a Pre-Seed round of $1,000,000, with Sanara Ventures as a lead investor.
- How much did IMedis raise in its crowdfunding campaign?
- In January 2020, IMedis raised $1,300,000 through an Equity crowdfunding campaign via ExitValley.
- When did IMedis receive CE approval for its radiology scans in the EU?
- IMedis received CE approval for its radiology scans in the EU in January 2021.
- What was IMedis's most recent funding round?
- IMedis's most recent funding round was a Convertible Debt round of $1,400,000 in October 2021.
- How many employees does IMedis have?
- IMedis has an employee count in the 500+ range, with an exact count of 1037 employees.